BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 463668)

  • 1. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. 2. Characteristics of a metastasizing variant of a chemically induced lymphoma.
    Schirrmacher V; Shantz G
    Adv Exp Med Biol; 1979; 114():769-75. PubMed ID: 463668
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.
    Schirrmacher V; Shantz G; Clauer K; Komitowski D; Zimmermann HP; Lohmann-Matthes ML
    Int J Cancer; 1979 Feb; 23(2):233-44. PubMed ID: 761943
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
    Bosslet K; Schirrmacher V; Shantz G
    Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of macrophage tumor cytostasis by tumor-induced ascites.
    Gemsa D; Kramer W; Napierski I; Bärlin E; Till G; Resch K
    J Immunol; 1981 Jun; 126(6):2143-50. PubMed ID: 7229369
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1976 Jan; 33(1):9-14. PubMed ID: 1252330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R; Grant CK
    Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
    Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
    J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
    [No Abstract]   [Full Text] [Related]  

  • 15. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological response in the mouse brain: I. Transplantation immunity to mouse lymphoma graft.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):191-201. PubMed ID: 3248016
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.
    Altevogt P; Kurnick JT; Kimura AK; Bosslet K; Schirrmacher V
    Eur J Immunol; 1982 Apr; 12(4):300-7. PubMed ID: 6124426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Demonstration of the antitumour effect of in vivo macrophage activation.
    Parr I
    Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4607926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.